Oncimmune (LON:ONC) Posts Earnings Results

Oncimmune (LON:ONC) posted its quarterly earnings data on Monday. The company reported GBX (4.72) (($0.06)) earnings per share for the quarter, Digital Look Earnings reports. Oncimmune had a net margin of 586.08% and a negative return on equity of 760.96%.

Oncimmune Stock Down 0.3 %

ONC stock opened at GBX 8.65 ($0.11) on Tuesday. Oncimmune has a twelve month low of GBX 8 ($0.10) and a twelve month high of GBX 31 ($0.38). The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The stock has a market cap of £6.41 million, a P/E ratio of -288.33 and a beta of 1.19. The business’s 50-day moving average price is GBX 13.48 and its 200-day moving average price is GBX 14.81.

About Oncimmune

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.